$CHRS
Coherus Oncology, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CHRS up today? It is at $1.41 (+6.82%), and our scanner flagged it 27 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CHRS spikes, and full due diligence on CHRS — key stats, earnings, dilution and insider activity. Free.
Get free $CHRS alerts the moment volume spikes
Our scanner flagged $CHRS 27 times in the last 30 days. Create a free account to track $CHRS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.41
- Change today
- +6.82%
- Previous close
- $1.32
- 52-week range
- $1.09 – $2.62
- Market cap
- $219M
- Institutional own.
- 52.23%
- Total held
- 54.7%
- Tradeable float
- 70.1M 45% of shares · after 2% insiders + 52% institutions
- Short interest
- 24.5M ▲ +3% vs prior · as of 2026-07-31
- Short % of float
- 35.0%
- Days to cover
- 53.6d
- Avg daily volume
- 1.4M
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 1.0x
- 15mthin
- 0.5x
- 1hthin
- 0.5x
- 1D
- --
Get free CHRS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CHRS up today?
Here is the latest on CHRS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CHRS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying7 buys, 0 sells last 3 months (9/2 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Newton Charles W. Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
Wahlstrom Mats Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
O'Donnell-Tormey Jill Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
Ryan Michael Lee Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
Newcomer Lee Nisley Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
Karachun Rita A Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
Satvat Ali J. Director | Acquired (grant/award) | +30K 0.02% of company | n/a | 30K | n/a | Jun 5, 26 |
Lanfear Dennis M Officer | Acquired (grant/award) | +375K 0.2% of company | added 56% | 1.05M | n/a | Jan 23, 26 |
Mcmichael Bryan J Officer | Acquired (grant/award) | +113K 0.07% of company | added 100% | 134K | n/a | Jan 22, 26 |
Lanfear Dennis M Officer | Sold (automatic/other) | -12K | sold 1.7% | 673K | $18K at $1.55 | Jan 20, 26 |
Mcmichael Bryan J Officer | Sold (automatic/other) | -2K | sold 7.5% | 21K | $3K at $1.55 | Jan 20, 26 |
Wahlstrom Mats Director | Sold (automatic/other) | -100K 0.06% of company | n/a | n/a | $74K at $0.740 | May 23, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $CHRS runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$CHRS Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CHRS Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to CHRS
Comparable names in biological products, (no diagnostic substances), closest in size first.
CHRS stock FAQ
Why is $CHRS up today?
Here is the latest on CHRS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CHRS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the CHRS stock price today?
CHRS last traded at $1.41, up 6.82% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CHRS alerts?
The CHRS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CHRS 27 times in the last 30 days.
What exchange is CHRS on?
CHRS (Coherus Oncology, Inc. Common Stock) trades on XNAS, with a market cap of about $219M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is CHRS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CHRS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.